* KEYNOTE *

A Guide to Drug Development, Current Approvals, and Drug Use in Aquaculture

Stacey Pulver, DVM

Biologist, Aquaculture Drugs Team, Center for Veterinary Medicine, US Food and Drug Administration 

BIOSKETCH

Dr. Pulver received her B.S. in Marine Biology from the University of North Carolina -Wilmington in 1999 and her D.V.M. from North Carolina State University College of Veterinary Medicine in 2005. Currently, she is a Biologist (Aquaculture) on the Aquaculture Drugs Team at the Food and Drug Administration’s Center for Veterinary Medicine. As part of the new animal drug application process, she reviews target animal safety and effectiveness studies that are submitted to support the approval of aquaculture drugs. During the last 16 years, Dr. Pulver has reviewed drug submissions for fish and shellfish, which included review of protocols, scientific data to support drug development, user safety, labeling, adverse drug events, and bioresearch monitoring assessments.

 

Outside of FDA, she played an active role in organizing the Eastern Fish Health Workshop from 2014 to 2020. Prior to joining FDA in 2007, she spent two years as a veterinary intern at the National Aquarium in Baltimore. She currently resides in the Chicago suburbs with her husband, two children, and two crazy beagles.